Dr Lalchandani Labs Fact Sheet, Dr Lalchandani Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Dr Lalchandani Labs Fact Sheet    (DLLL)


Revealing on July 30th: Asset Class Outlook and Economic View Post Covid 19


Here is the latest financial fact sheet of Dr Lalchandani Labs. For more details, see the Dr Lalchandani Labs quarterly results and Dr Lalchandani Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

DR LALCHANDANI LABS Price History

Price Rs 26.1
Mkt Cap Rs m 113
Vol '000 4.0
P/E X  
P/CF X 12.6
EPS (TTM) Rs 0.0
% ch % -0.2
No. of shares m 4.33
% ch week % 11.5
% ch 1-mth % 7.6
% ch 12-mth % 153.4
52 week H/L Rs 29.2/8.0
(As on Jul 27, 2021 03:35:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

DR LALCHANDANI LABS Financials

No. of Mths
Year Ending
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
5-Yr Chart
Click to enlarge
DR LALCHANDANI LABS EQUITY SHARE DATA
High RsNA3222 
Low RsNA188 
Sales per share (Unadj.) Rs9.512.214.1 
Earnings per share (Unadj.) Rs0.91.21.1 
Diluted earnings per shareRs0.61.21.1 
Cash flow per share (Unadj.) Rs1.32.02.1 
Dividends per share (Unadj.) Rs000 
Adj. dividends per shareRs0.000.000.00 
Dividend yield (eoy) %NM00 
Book value per share (Unadj.) Rs11.418.619.7 
Adj. book value per shareRs7.718.619.7 
Shares outstanding (eoy) m2.934.334.33 
Bonus / Rights / Conversions  --- 
Price / Sales ratio x02.01.1 
Avg P/E ratio x019.913.6 
P/CF ratio (eoy) x012.07.2 
Price / Book Value ratio x01.30.8 
Dividend payout %000 
Avg Mkt Cap Rs m010665 
No. of employees `000NANANA 
Total wages/salary Rs m376 
Avg. sales/employee Rs ThNMNMNM 
Avg. wages/employee Rs ThNMNMNM 
Avg. net profit/employee Rs ThNMNMNM 
DR LALCHANDANI LABS INCOME DATA
Net Sales Rs m285361 
Other income Rs m000 
Total revenues Rs m285361 
Gross profit Rs m61213 
Depreciation Rs m134 
Interest Rs m212 
Profit before tax Rs m477 
Minority Interest Rs m000 
Prior Period Items Rs m000 
Extraordinary Inc (Exp) Rs m000 
Tax Rs m122 
Profit after tax Rs m355 
Gross profit margin %22.122.820.8 
Effective tax rate %26.025.828.2 
Net profit margin %9.410.17.8 
DR LALCHANDANI LABS BALANCE SHEET DATA
Current assets Rs m375876 
Current liabilities Rs m161419 
Net working cap to sales %77.384.193.5 
Current ratio x2.44.14.1 
Inventory Days Days463933 
Debtors Days Days149127199 
Net fixed assets Rs m243840 
Share capital Rs m294343 
"Free" reserves Rs m43742 
Net worth Rs m338185 
Long term debt Rs m13615 
Total assets Rs m62101119 
Interest coverage x3.26.34.6 
Debt to equity ratio x0.40.10.2 
Sales to assets ratio x0.40.50.5 
Return on assets %6.86.65.5 
Return on equity %7.96.65.6 
Return on capital %11.19.98.5 
Exports to sales %000 
Imports to sales %000 
Exports (fob) Rs m000 
Imports (cif) Rs m000 
Fx inflow Rs m000 
Fx outflow Rs m000 
Net fx Rs m000 
DR LALCHANDANI LABS CASH FLOW
From Operations Rs m 6 -4 -1 
From Investments Rs m -13 -19 -5 
From Financial Activity Rs m 16 35 9 
Net Cashflow Rs m 9 11 2 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Indian Promoters 60.8%
Foreign collaborators 0.0%
Indian inst/Mut Fund 0.0%
FIIs 0.0%
ADR/GDR 0.0%
Free float 39.2%
Shareholders 143
Pledged promoter(s) holding 0.0%
 

Company Information

REGD OFF M-20 Basement, Greater Kailash, Part-1 South Delhi, New Delhi - 110048
E-MAIL NA WEB www.lalchandanipathlab.com
TEL 011 49057058/59 FAX
SECTOR HOSPITAL & HEALTHCARE SERVICES GROUP Private sector
TR AGENT Cameo Corporate Services Ltd, Subramanian Buildings No 1, Club House Road
YEAR OF INC: 2011 BSE CODE: 541299 FV (Rs): 10 DIV YIELD (%): -

More Hospital & Healthcare Services Company Fact Sheets:   PROCTER & GAMBLE HEALTH  NGL FINE CHM  INDRAPRASTHA MEDICAL  SMS PHARMA  NATURAL CAPS  

Compare DR LALCHANDANI LABS With:   PROCTER & GAMBLE HEALTH  NGL FINE CHM  INDRAPRASTHA MEDICAL  SMS PHARMA  NATURAL CAPS  




Today's Market

Sensex Ends 274 Points Lower; Dr Reddy's Laboratories and Cipla Among Top Nifty Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended lower.

Views on news

Glenmark Life Sciences IPO Opens Tomorrow: Few Points to Know Before Applying (Views On News)

Jul 26, 2021

All you need to know about the IPO of Glenmark Life Sciences.

Why Did Pharma Stocks Surge? (Views On News)

Jul 17, 2021

A look into the factors contributing to the rally in pharma stocks.

Bajaj Healthcare Rallies 11% on DRDO Nod to Manufacture Oral Covid Drug (Views On News)

Jul 8, 2021

Bajaj Healthcare has more than doubled investors' wealth in the year 2021 so far. The counter has delivered over 240% return in the last one year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

KIMS Shares Make Strong Debut Listing at a 22% Premium (Views On News)

Jun 28, 2021

KIMS shares pare gains after making a strong debut on the exchanges.

More Views on News

Most Popular

RBI Opens a New Market for Investors (Fast Profits Daily)

Jul 16, 2021

You now have a new way to create wealth. Grab it with both hands.

These Are the Best Stocks to Own (Fast Profits Daily)

Jul 22, 2021

Find out what I think are the best kind on stocks to own in the market.

A Better Way than the Zomato IPO to Play the Food Delivery Megatrend (Profit Hunter)

Jul 14, 2021

A unique backdoor way of making big profits from smallcap companies.

Heads Up Bank Nifty Traders (Fast Profits Daily)

Jul 14, 2021

The RBI raised bond yields on 10yr benchmark paper. That can impact Bank Nifty traders in the coming days.

India's Vulture Moment Against China (Fast Profits Daily)

Jul 15, 2021

India has a great opportunity to grab market share from China. Profit from it.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK DR LALCHANDANI LABS

  • Track your investment in DR LALCHANDANI LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR LALCHANDANI LABS

DR LALCHANDANI LABS - KIMS COMPARISON

COMPARE DR LALCHANDANI LABS WITH

MARKET STATS